Glaxo Said to Pay $250 Million to Settle Avandia Lawsuit

Glaxo Said to Pay $250 Million to Settle Avandia Lawsuit

JB Reed/Bloomberg

GlaxoSmithKline Plc's Avandia diabetes drug.